| HIDDEN cells are detected in HPV+ tonsil-derived epithelium and in HNSCC patient biopsies. a Representative H&E from n = 5 frames of the patient tonsil (Donor A) that was used to culture patient-derived tonsil keratinocytes to support experiments. Scale bar, 100 µm. b Representative IF showing few cells with light ELF3+ staining (arrows in inset) in tonsil tissue, indicating the relative absence of HIDDEN cells. Scale bar, 100 µm, n = 5 frames across tonsil tissue. c-f Representative images from n = 10 frames from a raft set generated from Donor A. c-f Scale bar, 50 µm. c Representative H&Es of epithelial rafts generated from tonsil-derived keratinocytes from Donor A that were either nucleofected with HPV16 or not nucleofected. Many more basal cells are seen in HPV+ tonsil epithelium. Scale bar, 50 µm d DNA-ISH for HPV genomes confirms HPV status of 3D rafts. e RNA-ISH for ELF3 and GPR110 shows few cells with puncta in HPV− rafts, and many puncta in HPV+ rafts. f IF staining reveals significant upregulation of ELF3+ HIDDEN cells in the suprabasal compartment. g, h Representative images from n = 10 frames from two p16+ and two p16− HNSCC biopsies. g RNA-ISH for HIDDEN cell biomarkers ELF3 and GPR110 shows many puncta in HPV+ vs HPV− HNSCC patient biopsies. Scale bar, 50 µm in the main image and 20 µm in an insert. h Representative images of HNSCC tumors stained by H&E stain and by IF. Stain for p16 confirms the HPV status of tumors and ELF3 staining demonstrates proteinlevel expression of HIDDEN cells, specifically in HPV+ HNSCCs. Scale bars, 100 µm.

| HIDDEN cells are detected in HPV+ tonsil-derived epithelium and in HNSCC patient biopsies. a Representative H&E from n = 5 frames of the patient tonsil (Donor A) that was used to culture patient-derived tonsil keratinocytes to support experiments. Scale bar, 100 µm. b Representative IF showing few cells with light ELF3+ staining (arrows in inset) in tonsil tissue, indicating the relative absence of HIDDEN cells. Scale bar, 100 µm, n = 5 frames across tonsil tissue. c-f Representative images from n = 10 frames from a raft set generated from Donor A. c-f Scale bar, 50 µm. c Representative H&Es of epithelial rafts generated from tonsil-derived keratinocytes from Donor A that were either nucleofected with HPV16 or not nucleofected. Many more basal cells are seen in HPV+ tonsil epithelium. Scale bar, 50 µm d DNA-ISH for HPV genomes confirms HPV status of 3D rafts. e RNA-ISH for ELF3 and GPR110 shows few cells with puncta in HPV− rafts, and many puncta in HPV+ rafts. f IF staining reveals significant upregulation of ELF3+ HIDDEN cells in the suprabasal compartment. g, h Representative images from n = 10 frames from two p16+ and two p16− HNSCC biopsies. g RNA-ISH for HIDDEN cell biomarkers ELF3 and GPR110 shows many puncta in HPV+ vs HPV− HNSCC patient biopsies. Scale bar, 50 µm in the main image and 20 µm in an insert. h Representative images of HNSCC tumors stained by H&E stain and by IF. Stain for p16 confirms the HPV status of tumors and ELF3 staining demonstrates proteinlevel expression of HIDDEN cells, specifically in HPV+ HNSCCs. Scale bars, 100 µm.

Source publication
Article
Full-text available
Persistent HPV16 infection is a major cause of the global cancer burden. The viral life cycle is dependent on the differentiation program of stratified squamous epithelium, but the landscape of keratinocyte subpopulations which support distinct phases of the viral life cycle has yet to be elucidated. Here, single cell RNA sequencing of HPV16 infect...

Contexts in source publication

Context 1
... and furthermore that C7 was composed of a greater proportion of cells derived from HPV+ vs HPV− specimens. C7 shares approximately one-quarter of genes (89 of 336) with the original C9 gene list (Supplementary Data 2). Altogether, this analysis confirms the increased presence of HIDDEN cells using a published dataset of HPV+ versus HPV− HNSCCs. (Fig. 9b). Tonsillar keratinocytes were derived from two separate donors, nucleofected with HPV16 episomes or maintained as negative controls, prior to generation of HPV+ and HPV− organotypic epithelial rafts ( Fig. 9c and Supplementary Fig. 6a). DNA-ISH for highrisk HPV confirmed the expected HPV status (Fig. 9d). RNA-ISH for ELF3 and GPR110 ( ...
Context 2
... Data 2). Altogether, this analysis confirms the increased presence of HIDDEN cells using a published dataset of HPV+ versus HPV− HNSCCs. (Fig. 9b). Tonsillar keratinocytes were derived from two separate donors, nucleofected with HPV16 episomes or maintained as negative controls, prior to generation of HPV+ and HPV− organotypic epithelial rafts ( Fig. 9c and Supplementary Fig. 6a). DNA-ISH for highrisk HPV confirmed the expected HPV status (Fig. 9d). RNA-ISH for ELF3 and GPR110 ( Fig. 9e and Supplementary Fig. 6b) and IF for ELF3 ( Fig. 9f and Supplementary Fig. 6c) validated significant upregulation of HIDDEN cells with HPV infection in tonsillar rafts derived from both donors. Next, ...
Context 3
... dataset of HPV+ versus HPV− HNSCCs. (Fig. 9b). Tonsillar keratinocytes were derived from two separate donors, nucleofected with HPV16 episomes or maintained as negative controls, prior to generation of HPV+ and HPV− organotypic epithelial rafts ( Fig. 9c and Supplementary Fig. 6a). DNA-ISH for highrisk HPV confirmed the expected HPV status (Fig. 9d). RNA-ISH for ELF3 and GPR110 ( Fig. 9e and Supplementary Fig. 6b) and IF for ELF3 ( Fig. 9f and Supplementary Fig. 6c) validated significant upregulation of HIDDEN cells with HPV infection in tonsillar rafts derived from both donors. Next, HNSCC patient biopsies were probed for gene and proteinlevel expression of HIDDEN cell ...
Context 4
... (Fig. 9b). Tonsillar keratinocytes were derived from two separate donors, nucleofected with HPV16 episomes or maintained as negative controls, prior to generation of HPV+ and HPV− organotypic epithelial rafts ( Fig. 9c and Supplementary Fig. 6a). DNA-ISH for highrisk HPV confirmed the expected HPV status (Fig. 9d). RNA-ISH for ELF3 and GPR110 ( Fig. 9e and Supplementary Fig. 6b) and IF for ELF3 ( Fig. 9f and Supplementary Fig. 6c) validated significant upregulation of HIDDEN cells with HPV infection in tonsillar rafts derived from both donors. Next, HNSCC patient biopsies were probed for gene and proteinlevel expression of HIDDEN cell biomarkers. Many cells with multiple puncta were ...
Context 5
... two separate donors, nucleofected with HPV16 episomes or maintained as negative controls, prior to generation of HPV+ and HPV− organotypic epithelial rafts ( Fig. 9c and Supplementary Fig. 6a). DNA-ISH for highrisk HPV confirmed the expected HPV status (Fig. 9d). RNA-ISH for ELF3 and GPR110 ( Fig. 9e and Supplementary Fig. 6b) and IF for ELF3 ( Fig. 9f and Supplementary Fig. 6c) validated significant upregulation of HIDDEN cells with HPV infection in tonsillar rafts derived from both donors. Next, HNSCC patient biopsies were probed for gene and proteinlevel expression of HIDDEN cell biomarkers. Many cells with multiple puncta were detected in two cases of p16+ HNSCCs by RNA-ISH but ...
Context 6
... upregulation of HIDDEN cells with HPV infection in tonsillar rafts derived from both donors. Next, HNSCC patient biopsies were probed for gene and proteinlevel expression of HIDDEN cell biomarkers. Many cells with multiple puncta were detected in two cases of p16+ HNSCCs by RNA-ISH but were largely absent in two cases of p16-negative HNSCCs (Fig. 9g). Similarly, ELF3 protein was robustly detected in HPV+, but minimally in HPV−, HNSCCs with HPV status confirmed by p16 staining (Fig. 9h). These Supplementary Data Suggest HIDDEN cells persist through stages of HPV-driven carcinogenesis into SCCs. Altogether, we show enrichment of HIDDEN cell biomarkers in patient-derived 3D in vitro ...
Context 7
... for gene and proteinlevel expression of HIDDEN cell biomarkers. Many cells with multiple puncta were detected in two cases of p16+ HNSCCs by RNA-ISH but were largely absent in two cases of p16-negative HNSCCs (Fig. 9g). Similarly, ELF3 protein was robustly detected in HPV+, but minimally in HPV−, HNSCCs with HPV status confirmed by p16 staining (Fig. 9h). These Supplementary Data Suggest HIDDEN cells persist through stages of HPV-driven carcinogenesis into SCCs. Altogether, we show enrichment of HIDDEN cell biomarkers in patient-derived 3D in vitro models of cutaneous, cervical, and tonsillar epithelium, as well as in HPV-driven premalignant and malignant patient biopsies that reflect ...

Similar publications

Article
Full-text available
Examining kidney fibrosis is crucial for mechanistic understanding and developing targeted strategies against chronic kidney disease (CKD). Persistent fibroblast activation and tubular epithelial cell (TEC) injury are key CKD contributors. However, cellular and transcriptional landscapes of CKD and specific activated kidney fibroblast clusters rema...
Article
Full-text available
Introduction: Age-related macular degeneration (AMD), an ever-increasing ocular disease, has become one of the leading causes of irreversible blindness. Recent advances in single-cell genomics are improving our understanding of the molecular mechanisms of AMD. However, the pathophysiology of this multifactorial disease is complicated and still an...
Preprint
Full-text available
Vibrio cholerae uses multiple strategies to resist predation by heterotrophic protozoa. For example, V. cholerae releases toxic compounds such as ammonium and pyomelanin, that can kill protists such as Tetrahymena pyriformis. V. cholerae also survives intracellularly and escapes as viable cells inside protozoan expelled food vacuoles (EFVs). We pre...
Preprint
Full-text available
Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from cd47-/- mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evide...

Citations

... To visualize genomic regions of interest we used Bacterial Artificial Chromosome (BAC) clones RP11-990E14 (hg38 -chr3:169,692,858-169,870,368 mapping to Telomerase RNA Component TERC), and RP11-662P23 (hg38 -chr5:56,420,151-56,608,998 mapping to the specific region of HPV16 integration on chromosome 5 in Tumor 4). In addition to human BAC clones we also used a plasmid containing the entire genomic sequence of HPV16 as reported in 100,101 . BAC DNA and HPV16 plasmid DNA was isolated and labeled by nick translation as we previously described 102,103 using the following dUTPs from Dyomics (Jena, GE, USA): DY-495-dUTP (within the green spectrum to visualize RP11-662P23); DY-530-aadUTP (within the gold spectrum to visualize RP11-990E14); and DY-590-dUTP (within the red spectrum to visualize HPV16). ...
Article
Full-text available
HPV infections are associated with a fraction of vulvar cancers. Through hybridization capture and DNA sequencing, HPV DNA was detected in five of thirteen vulvar cancers. HPV16 DNA was integrated into human DNA in three of the five. The insertions were in introns of human NCKAP1 , C5orf67 , and LRP1B . Integrations in NCKAP1 and C5orf67 were flanked by short direct repeats in the human DNA, consistent with HPV DNA insertions at sites of abortive, staggered, endonucleolytic incisions. The insertion in C5orf67 was present as a 36 kbp, human-HPV-hetero-catemeric DNA as either an extrachromosomal circle or a tandem repeat within the human genome. The human circularization/repeat junction was defined at single nucleotide resolution. The integrated viral DNA segments all retained an intact upstream regulatory region and the adjacent viral E6 and E7 oncogenes. RNA sequencing revealed that the only HPV genes consistently transcribed from the integrated viral DNAs were E7 and E6*I. The other two HPV DNA+ tumors had coinfections, but no evidence for integration. HPV-positive and HPV-negative vulvar cancers exhibited contrasting human, global gene expression patterns partially overlapping with previously observed differences between HPV-positive and HPV-negative cervical and oropharyngeal cancers. A substantial fraction of the differentially expressed genes involved immune system function. Thus, transcription and HPV DNA integration in vulvar cancers resemble those in other HPV-positive cancers. This study emphasizes the power of hybridization capture coupled with DNA and RNA sequencing to identify a broad spectrum of HPV types, determine human genome integration status of viral DNAs, and elucidate their structures.
... Using a 3D organotypic epithelial raft model, Bedard et al. discovered a keratinocyte subpopulation that was expanded and reprogrammed by HPV [106]. These cells (termed HPV-induced differentiation-dissonant epithelial nonconventional cells; HIDDEN) formed a distinct compartment in the infected epithelium and persisted from neoplastic lesions to outright cancer. ...
... These cells (termed HPV-induced differentiation-dissonant epithelial nonconventional cells; HIDDEN) formed a distinct compartment in the infected epithelium and persisted from neoplastic lesions to outright cancer. ELF3/ESE-1 was identified as a key regulator whose depletion in HPV + epithelium greatly reduced HIDDEN cell biomarker expression and compartment formation [106]. ...
Article
Full-text available
Head and neck squamous cell carcinoma (HNSCC) is one of the most frequent cancers worldwide. The main risk factors are consumption of tobacco products and alcohol, as well as infection with human papilloma virus. Approved therapeutic options comprise surgery, radiation, chemotherapy, targeted therapy through epidermal growth factor receptor inhibition, and immunotherapy, but outcome has remained unsatisfactory due to recurrence rates of ~50% and the frequent occurrence of second primaries. The availability of the human genome sequence at the beginning of the millennium heralded the omics era, in which rapid technological progress has advanced our knowledge of the molecular biology of malignant diseases, including HNSCC, at an unprecedented pace. Initially, microarray-based methods, followed by approaches based on next-generation sequencing, were applied to study the genetics, epigenetics, and gene expression patterns of bulk tumors. More recently, the advent of single-cell RNA sequencing (scRNAseq) and spatial transcriptomics methods has facilitated the investigation of the heterogeneity between and within different cell populations in the tumor microenvironment (e.g., cancer cells, fibroblasts, immune cells, endothelial cells), led to the discovery of novel cell types, and advanced the discovery of cell-cell communication within tumors. This review provides an overview of scRNAseq, spatial transcriptomics, and the associated bioinformatics methods, and summarizes how their application has promoted our understanding of the emergence, composition, progression, and therapy responsiveness of, and intercellular signaling within, HNSCC.
... probing host-microbial interactomics at the molecular level. Consider that numerous distinct keratinocyte subpopulations support the HPV life cycle compared with uninfected controls (Bedard et al. 2023). While focused on foreskin keratinocytes, a population of alternatively differentiated HPV+ keratinocytes was also found in cervical intraepithelial neoplastic and HPV+ head and neck squamous cell carcinoma samples. ...
Article
The human mouth, or oral cavity, is at the crossroads of our external and internal environments, and it is increasingly evident that local colonization of dental, oral, and craniofacial (DOC) tissues and cells by bacteria and viruses may also have systemic effects across myriad diseases and disorders. Better understanding of this phenomenon will require a holistic understanding of host-microbial interactions in both spatiotemporal and biogeographical contexts while also considering person-, organ-, tissue-, cell-, and molecular-level variation. After the acute phase interaction with microbes, the establishment of site-specific reservoirs constitutes an important relationship to understand within the human body; however, despite a preliminary understanding of how viral reservoirs originate and persist across the human body, the landscape of single-cell and spatial multiomic tools has challenged our current understanding of what cells and niches can support microbial reservoirs. The lack of complete understanding impacts research into these relevant topics and implementing precision care for microbial-induced or microbial-influenced diseases. Here, via the lens of acute and chronic microbial infections of the DOC tissues, the goal of this review is to highlight and link the emerging spatiotemporal biogeography of host-viral interactomics at 3 levels: (1) DOC cell types in distinct tissues, (2) DOC-associated microbes, and (3) niche-specific DOC pathologies. Further, we will focus on the impact of postacute infectious syndromes such as long COVID, neurodegenerative disorders, and other underappreciated postviral conditions. We will provide hypotheses about how DOC tissues may play roles systemically in these conditions. Throughout, we will underscore how COVID-19 has catalyzed a new understanding of these biological questions, discuss future directions to study these phenomena, and highlight the utility of noninvasive oral biofluids in screening, monitoring, and intervening to prevent and/or ameliorate human infectious diseases.
Article
Full-text available
Human papillomaviruses (HPVs) are commensal viruses with pathogenic potential. Their life cycle requires the proliferation and differentiation of keratinocytes (KCs) to form pluristratified epithelia. Based on the original organotypic epithelial raft cultures protocol, we provide an updated workflow to optimally generate pluristratified human epithelia supporting the complete HPV replicative life cycle, here called 3D full-thickness epithelial cultures (3Deps). We describe steps for HPV genome preparation, KC transfection, and dermal equivalent preparation. We then detail procedures for 3Deps culture, harvesting, and analysis.
Article
Full-text available
Cervical squamous cell carcinoma (CSCC) exhibits a limited response to immune-checkpoint blockade. Here we conducted a multiomic analysis encompassing single-cell RNA sequencing, spatial transcriptomics and spatial proteomics, combined with genetic and pharmacological perturbations to systematically develop a high-resolution and spatially resolved map of intratumoral expression heterogeneity in CSCC. Three tumor states (epithelial-cytokeratin, epithelial-immune (Epi-Imm) and epithelial senescence), recapitulating different stages of squamous differentiation, showed distinct tumor immune microenvironments. Bidirectional interactions between epithelial-cytokeratin malignant cells and immunosuppressive cancer-associated fibroblasts form an immune exclusionary microenvironment through transforming growth factor β pathway signaling mediated by FABP5. In Epi-Imm tumors, malignant cells interact with natural killer and T cells through interferon signaling. Preliminary analysis of samples from a cervical cancer clinical trial (NCT04516616) demonstrated neoadjuvant chemotherapy induces a state transition to Epi-Imm, which correlates with pathological complete remission following treatment with immune-checkpoint blockade. These findings deepen the understanding of cellular state diversity in CSCC.
Preprint
Full-text available
Uterine cervical cancer (UCC) has the second-highest mortality rate among malignant tumors of the female reproductive system. Immune checkpoint inhibitors (ICIs) have emerged as a promising therapeutic strategy for cervical cancer. However, the efficacy of PD-1 (programmed cell death protein 1) blockade combined with neoadjuvant chemotherapy (NACT) and the ensuing alterations within the tumor microenvironment need further investigation. We conducted single-cell RNA sequencing using 46,950 cells from nine sequential human cervical cancer tissues representing different stages of NACT and PD-1 blockade combination therapy. We delineated the trajectory of cervical epithelial cells and unveiled crucial factors involved in the combination therapy. Cell communication analysis revealed the inferred interaction strength decreased between T cell-cancer cells, while the communication between macrophage-cancer cells intensified after NACT therapy. We verified that macrophages are necessary for PD-1 blockade combination to exert antitumor effects in vitro. Detailed analysis unraveled the CD74-positive macrophages frequently interacted with the immunoreactive Epi 3 subgroup during neoadjuvant combination therapy. CD74 upregulation limited phagocytosis and stimulated M2 polarization. The CD74 blockade enhanced macrophage phagocytosis, resulting in decreased viability of cervical cancer cells in vitro and in vivo. This study unveils the dynamic microenvironment of UCC influenced by NACT and PD-1 blockade combination therapy, and targeting CD74 was a potential strategy to augment the therapy efficacy.